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Abstract. – OBJECTIVE: Osteoradionecrosis
(ORN) is a bone aseptic necrosis which devel-
ops on post-irradiated bone tissue of patients
who underwent radiotherapy for head-neck tu-
mors. The mandible presents a higher risk to
develop ORN, if compared to the maxillary
bone, due to its lower vascularization.
The aim of the present study is to clinically as-
sess the regenerative ability by the epithelial and
connective tissues, in response to ORN onset.
PATIENTS AND METHODS: Authors have
verified the importance of the surgical-pharma-
cological treatment, as an effective protocol for
eliminating the exposed bone sequestration, as
well as the teeth eventually damaged by the ra-
diotherapy, assessing that the epithelium can
regenerate only on healthy and vital tissues.
RESULTS: The reported patient underwent re-
section of a portion of the left mandible with an
incomplete healing after the surgery. A second
curettage was scheduled in order to remove the
bands of necrotic tissue and to obtain a clinical
remission of symptoms.
CONCLUSIONS: In patients undergoing ra-
diotherapy, the dental surgeon should be able
to give an early diagnosis of the dental and
maxillofacial related pathologies; he should al-
so detect all the possible infective sources and
administer any possible treatment in a short
time, before the beginning or the prosecution of
radiotherapy.
Key Words:
Osteoradionecrosis, Radiotherapy, Tissues healing.
Introduction
Bone tissue can be suffering from several dis-
eases that could lead to a tissue necrosis, and
some pathogenesis are paradoxically related to
the treatments of other pathologies: this is the
case of the BRONJ (Biphosphonates-Related Os-
teoNecrosis of the Jaws) and, undoubtedly, of the
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osteoradionecrosis (ORN). Osteoradionecrosis is
an aseptic necrosis which occurs in patients who
had undergone radiotherapy for tumors in the
head-neck area, without persistence of
neoplasia1. The physiopathology of ORN is de-
termined by the concurrent presence of hypovas-
cularization, hypocellularity and tissue hypoxia,
which compromise the vitality of the bone tissue.
The risk to incur an ORN is not predictable, but
it has been verified that this risk is related to the
dose of radiations which is generally more than
65 Gy and to the thickness of the irradiated
bone2,3. According to the studies reported in liter-
ature, ORN onset is between 3 and 27 months af-
ter the end of radiotherapy, even if in rare cases it
can develop even after 5 or more years from the
radiations. The risk to develop ORN covers an
indefinite period after irradiation4,5.
After radiant therapy, the common lesion
which early affects the maxillofacial area is the
mucositis: it appears as a diffused erythema with
disepithelized areas and ulcerations: the use of
new irradiation techniques, such as advanced lin-
ear accelerators and radiosurgery treatment sys-
tems, has determined a reduction in the incidence
and the severity of mucositis, however, the heal-
ing of mucositis could be complicated in smokers
and patients with poor oral hygiene6.
In the international literature there are only
few cases of osteoradionecrosis of the mandible
sufficiently severe to require a total mandibular
resection7; however, this incidence would de-
crease by avoiding some traumatic dental treat-
ments immediately after radiotherapy.
The risk of a second episode of ORN after a
proper surgical-pharmacological treatment of
the first appearance is low8. All literature shows
a progressive reduction of cases of ORN with
the incoming of the modern techniques of radio-
therapy9.
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Patients Sex Age Seat of the primary lesion Arising complications
1 M 57 Mandible Osteonecrosis
2 M 59 Maxilla Aggressive tooth decay
3 M 56 Minor salivary glands Radio-mucositis
4 F 55 Mandible Osteonecrosis
5 M 56 Tongue Aggressive tooth decay
6 M 67 Salivary glands (parotid) Radio-mucositis
7 M 70 Lips Radio-mucositis
8 M 68 Salivary glands (parotid) Radio-mucositis
Table I. A synoptic table describing the samples reported in this research.
Patients and Methods
Authors have verified the importance of the
surgical-pharmacological treatment, as an effec-
tive protocol for eliminating the exposed bone
sequestration, as well as the teeth eventually
damaged by the radiotherapy, assessing that the
epithelium can regenerate only on healthy and
vital tissues.
Exclusion criteria have established not to in-
clude such patients who underwent bisphospho-
nate therapy, as well as smokers, hard drinkers,
patients with autoimmune pathologies or with
hematologic disorders, patients at infective risk
and all the patients wearing removable prosthe-
ses. According to the above criteria, 7 men and 1
woman, aged between 55 and 70 years, with a
clinical history of carcinomas in the cervico-fa-
cial area (Table I), and recently treated with ra-
diotherapy (cobalt therapy of 45-65 Gy or inter-
stitial Curie-therapy), were recruited.
Following the cycles of radiotherapy, the pa-
tients underwent oral examination, revealing a
generally compromised periodontal and dental
condition.
We found 4 patients with radio-mucositis, 2
cases of aggressive caries associated with hypos-
alivation and reporting a sensations of xerosto-
mia and dysgeusia, and 2 cases of osteonecrosis
developed after radiation therapies. More specifi-
cally, all the patients who developed ORN under-
went tooth extraction immediately after the end
of the radiotherapy treatment, just in the area
where ORN has been diagnosed.
We report the case history of one of these pa-
tients: a male of 57 years old with an history of
multiple myeloma with the onset of the ORN on
the mandible, after the radiotherapy.
The diagnosis was based on clinical examina-
tions, which showed a chronic mucosal ulcer lo-
Etiopathogenesis of ORN
ORN of the jaws was initially considered as
the inevitable consequence of the triad: a) radia-
tions therapy, b) trauma, c) bacterial infection.
Radiations cause damage to the bone tissue
and they also reduce the ability of tissue vascu-
larization: the consequent condition of hypovas-
cularization and hypoxygenation damages the ac-
tivity of the involved cells, as well as the synthe-
sis of collagen and the entire process of tissue
reparation10.
Any type of trauma represents a front door in-
side the maxillary bones for those bacteria resid-
ing in the oral cavity. One of the traumas mostly
related with the onset of ORN is tooth extraction11.
A spontaneous onset of ORN (approximately
35% of cases) seems to be correlated with high
doses of radiations (>65 Gy); this form of ORN
normally appears within two years after radio-
therapy12. With the passing of the months, the ir-
radiated bone tissue becomes more fibrotic and
hypovascularized13.
The clinical diagnosis of ORN is based on
the observation of the exposed bone. Radiologi-
cal investigations typically show a reduced bone
density, the destruction of the cortex, the loss of
trabeculation of cancellous bone and, occasion-
ally, pathologic fractures. The computerized to-
mography (CT) usually shows anomalies in the
bone pattern, such as focal lytic areas, cortex ir-
regularity and loss of spongiosa trabeculation
on the symptomatic side: the normal anatomy of
the soft tissues surrounding such lesions is
deeply altered13.
ORN is a pathology that tends to move for-
ward very slowly, and it does not show the ten-
dency to any spontaneous recovery. The aim of
the present study is to clinically assess the regen-
erative ability by the epithelial and connective
tissues, in response to ORN onset.
seemingly healthy portion of that tissue sur-
rounding the lesion is an essential surgical pas-
sage to avoid a relapse of ORN in the same
place. The surgery continued with the excision
of the sub-mandibular and sub-digastric lymph
nodes, in order to histologically verify the ab-
sence of a lymph node involvement and to de-
termine the staging of the case.
Histological Examination
Bone and mucosa samples were collected dur-
ing the surgery and properly sent to the labs to
perform the histological examination.
Medical Therapy
At the end of surgical treatment, the patient re-
ceived a broad-spectrum antibiotic therapy togeth-
er with anti-inflammatory administered by intra-
venous administration. Daily rinses with saline so-
lution and hydrogen peroxide were performed to-
gether with 0.12% chlorhexidine rinses; topical
antimycotic therapy was also administered.
Results
After the surgery, patient showed an incom-
plete healing due to a severe post-surgical infec-
tion and to inconceivable violation of the prohi-
bition of eating solid food in the first days after
surgery. Therefore, a second curettage was
scheduled in order to remove the residual necrot-
ic tissue and to finally achieve a clinical healing
(Figure 2).
Histological Examination
The report of the Laboratory of Anatomy and
Pathologic Histology revealed the presence of
fragmentation of the bony trabeculae, a fibrotic
substitution of the fatty marrow and a chronic in-
filtrate of the adjacent tissues.
In the following weeks, the authors observed a
progressive increase of the symptomatology, and
despite the close observation by clinicians and
dentists, it developed a bacterial infection on the
sutures. The debridement of the inflamed tissue
around the suture was thus performed, followed
by the placement of a periodontal pack.
3 weeks later, the pain was greatly reduced
and there was a slow and progressive regenera-
tion of the mucosa.
Healing process was very slow, also due to the
complications occurred during the therapeutic
procedures: unfortunately, in this type of pa-
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Figure 1. Clinical appearance of the bone sequestrum, fol-
lowing the osteonecrosis process, developed on the left side
of mandibular bone, in the molar area: it’s easily observable
the necrotic bone with bacterial superinfection.
cated in the lower left area of the mandible, with
an exposure of necrotic bone tissue, affected from
a clinically evident bacterial infection (Figure 1).
Preparation To Treatment
To treating the osteonecrosis, the authors start-
ed with the cure of the decayed teeth together
with a slight and supragingival ablation of the
bacterial plaque and tartar by means of ultrasonic
instruments, in order to reduce the bacterial cont-
amination. Hematochemical and hemocoagula-
tive examinations were performed, moreover, a
cardiological examination was planned before to
proceed with the surgical removing of the necrot-
ic bone sequestrum. Blood pressure, glycemia
and dental panoramic were also planned, and fi-
nally the patient was psychologically prepared
for a proper approach to the operating room (pre-
operation counselling).
The Surgery
The surgery was performed under general
anesthesia. After disinfection of the surgical
area and administration of the proper anesthe-
sia, the upper part of the left hemi-mandible
was removed by means of tungsten burs and
scalpels: anyway, the left mandibular region
was preserved and all the necrotic tissue was re-
moved, together with a large section of seem-
ingly healthy bone tissue. The resection of a
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Figure 2. A slow and progressive regeneration of the mucous tissue is described in this picture. The figure A and the figure B
are the same. In B, 3 main areas have been highlighted. Area 1: is the zone where the early onset of bone necrosis appeared:
now that area has been covered by new mucosa, after surgical-pharmacological treatment. Area 2: is the pre-existing mucosa
showing signs of slight ischemia in marginal areas and a hypertrophy likely reactive to inflammation. Area 3: is the new bone
dehiscence which came out in the second phase of observation of the patient.
Prevention and Aggravating Factors
Regarding the prevention of ORN, the first ap-
proach should always improve the patients oral
condition, taking into account that high-risk pro-
cedures, such as major oral surgery (cystectomy,
drainage of the oral cavity, etc.) and minor oral
surgery (simple or complex exodontia), should
not be performed in the immediate post-irradia-
tion period; radio-induced dental decay, frequent-
ly observed in patients undergoing radiotherapy,
is often a result of the changes induced by radia-
tions on the glandular salivary tissue: this condi-
tion leads to hyposalivation and xerostomia able
to develop severe dental caries14.
Prevention of ORN of the jaws is effective if
before the radiotherapy the dentist can eliminate
all the intraoral co-morbidity factors.
In many patients who underwent high-dose ra-
diotherapy, it was found a severe bacterial infec-
tion, particularly from Gram-negative pathogens:
it has been supposed that the selective elimina-
tion of these bacteria by administration of poly-
antibiotic therapy (recent studies have associated
Polimixine E + Tobramicine + Amphotericin B
with encouraging results) has a prophylactic ef-
tients, riepithelization is a very slow process and
weekly treatments of hyperbaric oxygen therapy
could have helped the replacement of the missing
tissues; therefore, in this case, the authors were
unable to provide oxygen therapy, due to the
presence of oncologic patient.
Discussion
Radiotherapy is an important aid for the treat-
ment of oncological patients. It is commonly
used for a wide number of oncological patholo-
gies, and its ability to treat cancer has been im-
proved through the last ten years.
Modern irradiation techniques ensure both ac-
curate dose distribution and precise beam deliv-
ery, without inducing the tissue toxicities arising
from the use of chemotherapic drugs. However,
early and late effects of irradiation still constitute
a significant issue for clinicians: particularly
complicated is the management of the ischemic
avascular bone necrosis frequently observed on
the maxillary bones of H&N oncological
patients1-14.
fect on the development of mucositis and on the
superinfection of exposed necrotic bone in ORN.
Thus, the eradication of these bacteria has been
associated to a reduction of the mucositis15.
In literature, contrasting data have been report-
ed about the correlation between the fractiona-
tion of the dose of radiotherapy and the risk to
develop ORN. For instance, a lower incidence of
ORN was observed in the CHART therapy (Con-
tinuos Hyperfractionated Accelerated Radiother-
apy), consisting in the administration of 54 Gy in
36 fractions, during 12 consecutive days (3 frac-
tions a day of 1.5 Gy)16.
Age does not seem to play an important role
regarding the risk to develop ORN; instead, high-
er risks related to an onset of ORN were ob-
served in the edentulous patients. Other patient-
related co-factors include, for example, the pres-
ence of periodontitis, a poor oral hygiene and the
smoking habit.
Therapy of ORN
The hyperbaric oxygen therapy (HBOT), asso-
ciated with the topical surgery and with a proper
antibiotic therapy, could aid the healing process
of necrotic bone tissues, mainly thanks to the in-
creased oxygenation of the treated tissues17.
It will be useful to administer corticosteroids
in long-term fractionated therapy. Unconvention-
al therapeutic measures could be taken into con-
sideration, such as: ultrasounds, electrotherapy or
magneto-therapy; however, up to now, the surgi-
cal therapy is undoubtedly the most effective
treatment. Surgery is strongly recommended in
cases of recurring pain, pathological fractures
and large areas of exposed necrotic bone. The
immediate bone replacement, by using fibular
grafts, scapular osteo-cutaneous flap or iliac crest
grafts, determines an outstanding functional-es-
thetic result. Promising results have been ob-
served with omental transfers18.
Advantages from the Hyperbaric Oxygen
Therapy (HBOT)
There is some evidences that the HBO is more
effective than the conventional antibiotic prophy-
laxis (5% and 30% incidence of ORN, respec-
tively).
HBO stimulates a neo-angiogenesis, improves
the tissue perfusion and stimulates the formation
of collagen19; therefore, HBO aids the healing
process of the damaged tissues. Correctly, HBO
should be used before and after radiotherapy,
however, it should always considered that its use
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is strictly not recommended to oncological pa-
tients.
Osteonecrosis is a consequence of several fac-
tors, apart from radiations: literature reports many
cases of osteonecrosis of the jaws related to the
use of bisphosphonates, drugs commonly used in
the treatment of osteoporosis and bone cancer
metastasis. The American Association of Oral and
Maxillofacial Surgeons (AAOMS) defined the
bisphosphonate-related osteonecrosis of the jaws
(BRONJ) as the presence of exposed necrotic
bone in the maxillofacial region that does not heal
within 8 weeks after clinical identification, in a
patient currently or previously treated with BPs,
who has never undergone radiotherapy to the
jaws. Actually, it’s well established that patients
under oral bisphosphonate use show a lower risk
for bone necrosis of jaw, and this bone necrosis
seems to be generally more limited and more re-
sponsive to treatment if comparing to ONJ in pa-
tients taking intravenous formulations20.
There are two fundamental aims in the treat-
ment of ORN: the elimination of the necrotic
bone and the improvement of vascularization in
the remaining vital tissues, damaged by radia-
tions. The first step in the treatment of osteora-
dionecrosis is the resective surgery of the avascu-
lar bone: the removal of the necrotic bone tissue
eliminates any reservoir of infection and inflam-
mation, but it does not influence the improve-
ment of vascularization of the diseased but still
vital adjoining tissue.
As osteoradionecrosis is the result of a hypo-
vascularization and not necessarily the result of
an infection, the antibiotic therapy is considered
additional. The most important part of the treat-
ment is the surgical one, and in fact HBO is an
adjuvant too.
In this light, the approach to osteonecrosis can
be surely complicated due to the frequency of in-
fections of exposed bone: this additional side-ef-
fect is induced from the hypofunction of the sali-
vary glands, following the radiotherapy; this ef-
fect can be reduced by a preventive stimulation
of the residual secretory capacity of the salivary
glands, by means of salivary substitutes; the sur-
gical transposition of the submandibular gland
was described as a successful methodology for
the prevention of hyposalivation, but its indica-
tions are limited6.
In our study we found that bone lesions are
important side effects of the oncological radio-
therapy, especially in tumors of the head and
neck area4.
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In literature, ORN is histologically character-
ized by the destruction of osteocytes, the absence
of osteoblasts and the lack of newly formed os-
teoid tissue; the thickened vessels, located in the
irradiation area, are the result of fibrosis, endar-
teritis and periarteritis10-13. At the level of the
bone marrow, there is an infiltrate of lympho-
cytes, macrophages and plasma cells12,13. Due to
the complexity of the pathogenic process, it is
impossible to define a clear separation between
pathologic and healthy marrow. In fact, the bone
section subject to radiations develops vascular
degenerations leading to an high susceptibility to
develop the osteoradionecrosis. Osteocytes and
blood vessels are often irreversibly compromised
but, in spite of this, non-vital bone fragments and
lesions can however regenerate themselves.
In our study we have assessed how a correct
and standardized protocol can be an useful aid in
the right management of the osteonecrosis, re-
ducing the risk of a relapse and a second surgery
in the same site.
Conclusions
In patients undergoing radiotherapy, the dental
surgeon should be able to give an early diagnosis
of the dental pathologies, detect possible infec-
tive foci and administer any possible treatment in
a short time, before the beginning of radiothera-
py. Once the radiant therapy has started, traumas
on mucosal tissues are to be absolutely avoided,
as well as more invasive treatments on bone tis-
sues.
Finally, patients should be thoroughly motivat-
ed to oral hygiene, and it is advisable to schedule
oral hygiene sessions to prevent possible inflam-
mations, parodontopathies and the consequent
mobility of teeth. The regular oral prophylaxis
and the daily fluoride applications are very im-
portant too. However, the treatment to follow
cannot be standardized, as confirmed by litera-
ture data.
Among the different orientations of basic
therapy, magnetotherapy could be also suggest-
ed; in case of tissues inflammation, adjuvant
therapies should be used to stimulate the indi-
vidual reactivity to bacterial infections, particu-
larly Staphylococcus and Actinomyces (the most
frequently detected pathogens); whereas in cas-
es of sequestration, the clinician can have re-
course to ultrasound therapy in association with
conventional therapies. It is also advisable to
provide a special diet to these patients, so to re-
duce some micotic infections particularly relat-
ed to a diet rich in carbohydrates. Following the
indications reported in this research article, to-
gether with a careful prophylaxis before radio-
therapy and with the elimination of co-morbidi-
ty factors, we can reduce the incidence of com-
plications resulting from radiations.
Furthermore, recent studies on pathogenic
mechanisms, and recent gains in the use the an-
tioxidants in terms of therapy, have helped to find
a new practicable pathway in the desert of the
management of osteoradionecrosis.
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